Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2
In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.
Read the full articleYou might also wanna read
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease
Conditions : Alzheimer Blood Biomarkers; Alzheimer's Disease (AD) Interventions : Diagnostic Test: Plasma p-tau217 and neurofilament light c
Blood-based test can predict risk of developing symptoms of Alzheimer's up to a decade early
A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged about the e
IFM | Innovative Diagnostic Tools and Workflows for Suspected Alzheimer's in Primary Care
In this special edition of Inside Family Medicine , sponsored by Roche Diagnostics, h ost Darren Sextro talks with brain health experts Dean
Blood Tests for Alzheimer's Disease Are Showing Promise
New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of just amyloid.
Alzheimer’s biomarkers in dental practice: Is innovation outpacing readiness?
Practices should be cautious about adopting complex biomarker tests such as APOE genotyping and blood-based Tau assays. Here's why.
Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease
A blood test that helps diagnose Alzheimer's might also forecast whether healthy older adults will develop symptoms.
Comments
Sign in to join the conversation.
No comments yet. Be the first.